Place the template
A sacrificial template is placed in the chip. Cells can be grown on its surface beforehand, or seeded later.
Simplicity for the organ-on-a-chip revolution
FiberCyte builds perfusable, blood-vessel-like channel networks inside hydrogels: capillary-scale, cell-lined, and imaging-compatible. No bioprinter, no new equipment.
Cell-lined perfusable lumen, at true capillary scale.
Hydrogel matrices supported, not locked to one gel.
Steps from template to perfusable channel.
The problem
Building complex 3D tissue models is slow, expensive and limited in resolution. Bioprinting, today's go-to for microvascular networks and nerve guides, struggles the moment living cells are involved, demanding extensive optimization and costly equipment.
Without a simpler way to form perfusable, cell-lined channels inside hydrogels, organ-on-a-chip models stay too simple to faithfully replicate human tissue.
What FiberCyte does
FiberCyte forms perfusable channel networks inside hydrogels without a printer. A sacrificial template defines the geometry, cells line the channels, and other cell types populate the surrounding gel.
Cells can grow directly on the template before embedding, or be seeded later. The template is then removed under mild conditions in minutes, leaving cell-lined, perfusable channels behind.
No toxic solvents. No cell damage. No new equipment. It works in the chips you already run.
How it works
No printer, no post-seeding, no pre-treatment.
A sacrificial template is placed in the chip. Cells can be grown on its surface beforehand, or seeded later.
Hydrogel containing your cells is cast around the template and crosslinked, locking the geometry in place.
The template is removed under mild conditions in minutes. What remains is a clean, cell-lined, perfusable channel.
Demonstrated
Across physiologically relevant tissue models, at advanced proof-of-concept stage.
Endothelial cells and astrocytes in physiologically correct geometry.
Endothelial-lined channels with supporting stromal cells.
Schwann-cell conduits guiding human axon growth across channels.
Endometriosis organoids reached and innervated through the channels.
Multi-branch architectures, not just single straight channels.
Proof-of-concept on an industrial partner's robotic system.
Who it's for
If a ball of cells is enough, we are not the choice. If it is not, we are the accessible route.
Drug screening and preclinical testing with more predictive human models.
Disease modeling, tissue microenvironment studies and innervation, in a reproducible format.
Integrate with existing chips to enable richer hydrogel architectures.
About
We work with academic and industrial partners to bring perfusable 3D models into standard organ-on-chip workflows.
FiberCyte is being developed at the MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University.
Working with early partners
We're accepting pilot collaborations with pharma, biotech, academic and organ-on-chip teams.
Get in touchNot ready for a pilot? We're also running short conversations with people building 3D models today: 20 minutes, no pitch. Happy to talk.